Atomwise Inc (Atomwise), formerly Chematria Inc, uses artificial intelligence (AI) technology to discover and develop new medicines and agricultural compounds.

Its technology, AtomNet, is a deep learning neural network, which foretells the bioactivity of small molecules that find application in drug discovery. Atomwise’s AtomNet technology harnesses robust deep-learning algorithms and supercomputers to examine millions of molecules for potential treatments.

The company works in partnership with pharmaceutical and agrochemical companies, academic institutions and hospitals for advancing research in diverse areas such as leukaemia, Ebola, multiple sclerosis, fungicides and nematicides, using its capabilities in AI.

Atomwise is headquartered in San Francisco, California, the US.